Financials

Discussions Technicals Forecast Seasonals

6785 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ALAR PHARMACEUTICALS INC operating, investing, and financing activities

6785 free cash flow for Q3 24 is -20.33 M TWD. For 2023, 6785 free cash flow was 411.25 M TWD and operating cash flow was 417.59 M TWD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—